{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001039456.2:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_001039456.2",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant associated with increased kinase activity"
        },
        {
          "HGVS": "NM_001039456.2:c.4322G>T",
          "cDNA Change": {
            "transcript": "NM_001039456.2",
            "ref": "G",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C variant linked to altered protein interactions"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005319"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing LRRK2 variants",
        "Description": "HEK293 cells were transfected with plasmids encoding wild-type or mutant LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039456.2:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of downstream targets (e.g., Rab10) in cells expressing G2019S compared to wild-type."
        },
        {
          "Variant": "NM_001039456.2:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Reduced interaction with PINK1 in R1441C-expressing cells, but no significant change in kinase activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing cells served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 15% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels exceeding 30% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y cells with LRRK2 variants",
        "Description": "SH-SY5Y cells were stably transfected with LRRK2 variants and used for co-immunoprecipitation experiments."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001039456.2:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Enhanced interaction with 14-3-3 proteins in G2019S-expressing cells."
        },
        {
          "Variant": "NM_001039456.2:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered interactions",
          "Result Description": "Reduced binding to PINK1 in R1441C-expressing cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was repeated twice."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing cells served as positive controls."
      },
      "Basic negative control": {
        "Basic negative控制": "Yes",
        "Description": "Cells without LRRK2 overexpression served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "1"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for comparison."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Interaction intensity within 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Interaction intensity deviating by more than 30% from wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Primary neurons",
        "Material Name": "Patient-derived iPSC neurons with LRRK2 variants",
        "Description": "iPSC-derived neurons from Parkinson's patients carrying LRRK2 variants were used for viability assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039456.2:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "toxicity",
          "Result Description": "Significant reduction in neuronal viability (50% decrease) in G2019S-expressing neurons compared to controls."
        },
        {
          "Variant": "NM_001039456.2:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "toxicity",
          "Result Description": "Moderate reduction in viability (30% decrease) in R1441C-expressing neurons."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type iPSC neurons served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated control neurons served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with Dunnett's post-test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Viability >80% of control levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Viability <60% of control levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}